The Health Research Council of New Zealand (HRC) and Breast Cancer Cure (BCC) are pleased to announce the funding of an additional research project that will aim to contribute to the goal of improving and ultimately ensuring breast cancer survival in New Zealand. This research project, led by Dr Evelyn Sattlegger at Massey University, will seek to test a new drug target that has the potential to impair breast cancer cell growth.
The following details includes the named principal investigator only.
Dr Evelyn Sattlegger
Massey University
Testing a new drug target that promises to impair breast cancer cell growth
24 months, $100,000 (funded by the HRC and Breast Cancer Cure)
Read a lay summary of this project.
This application was originally submitted to Breast Cancer Research in New Zealand 2015 initiative, which is a joint funding partnership between Breast Cancer Cure, The New Zealand Breast Cancer Foundation and the HRC.